| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 101.31B | 102.54B | 100.33B | 95.90B | 91.57B | 86.29B |
| Gross Profit | 26.14B | 25.86B | 25.34B | 24.10B | 22.32B | 21.33B |
| EBITDA | 4.45B | 4.56B | 4.31B | 4.06B | 3.01B | 3.41B |
| Net Income | 2.76B | 2.22B | 2.61B | 2.16B | 1.45B | 1.65B |
Balance Sheet | ||||||
| Total Assets | 50.79B | 52.15B | 50.85B | 51.26B | 48.76B | 46.32B |
| Cash, Cash Equivalents and Short-Term Investments | 29.00B | 29.13B | 27.84B | 29.15B | 27.17B | 25.50B |
| Total Debt | 11.35B | 9.36B | 9.80B | 10.62B | 11.27B | 10.84B |
| Total Liabilities | 33.07B | 32.61B | 32.75B | 35.13B | 34.05B | 32.70B |
| Stockholders Equity | 17.72B | 19.53B | 18.10B | 16.13B | 14.72B | 13.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.54B | 558.42M | 3.89B | 1.83B | 1.11B |
| Operating Cash Flow | 0.00 | 3.28B | 1.52B | 4.62B | 2.53B | 1.83B |
| Investing Cash Flow | 0.00 | -764.96M | -1.38B | -1.23B | -1.03B | -1.27B |
| Financing Cash Flow | 0.00 | -1.23B | -1.46B | -1.43B | -114.84M | 2.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥15.84B | 7.21 | ― | 3.81% | 7.75% | 71.62% | |
76 Outperform | ¥43.07B | 15.10 | ― | 2.56% | 7.38% | 4.61% | |
75 Outperform | ¥53.79B | 13.79 | ― | 2.94% | 11.86% | 17.29% | |
75 Outperform | ¥42.61B | 6.09 | ― | 2.28% | 7.47% | 12.35% | |
65 Neutral | ¥15.61B | 7.97 | ― | 3.47% | 2.20% | -14.97% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥13.58B | 36.70 | ― | 0.84% | 7.94% | 48.30% |